
Sherman D. Basinger
Examiner (ID: 6218)
| Most Active Art Unit | 3105 |
| Art Unit(s) | 3617, 3612, 2899, 3105, 3102 |
| Total Applications | 3087 |
| Issued Applications | 2627 |
| Pending Applications | 85 |
| Abandoned Applications | 375 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7200577
[patent_doc_number] => 20050042295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Anti-angiogenic compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/962578
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 82
[patent_no_of_words] => 46530
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962578 | Anti-angiogenic compositions and methods of use | Oct 12, 2004 | Abandoned |
Array
(
[id] => 7082718
[patent_doc_number] => 20050048098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents'
[patent_app_type] => utility
[patent_app_number] => 10/933971
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4904
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048098.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933971 | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents | Sep 1, 2004 | Abandoned |
Array
(
[id] => 6959062
[patent_doc_number] => 20050215432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Aqueous neonicotinoid compositions for seed treatment'
[patent_app_type] => utility
[patent_app_number] => 10/919626
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6881
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10919626
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/919626 | Aqueous neonicotinoid compositions for seed treatment | Aug 16, 2004 | Issued |
Array
(
[id] => 7419556
[patent_doc_number] => 20040228917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer'
[patent_app_type] => new
[patent_app_number] => 10/871251
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10373
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10871251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/871251 | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer | Jun 17, 2004 | Issued |
Array
(
[id] => 641506
[patent_doc_number] => 07122205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Bioerodable polymeric adhesives for tissue repair'
[patent_app_type] => utility
[patent_app_number] => 10/811649
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10572
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10811649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/811649 | Bioerodable polymeric adhesives for tissue repair | Mar 28, 2004 | Issued |
Array
(
[id] => 7436610
[patent_doc_number] => 20040185098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Controlled release oxycodone compositions'
[patent_app_type] => new
[patent_app_number] => 10/809766
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8647
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185098.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809766 | Controlled release oxycodone compositions | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7383497
[patent_doc_number] => 20040180023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Cosmetic composition comprising at least one fixing polymer and at least one amphoteric starch'
[patent_app_type] => new
[patent_app_number] => 10/806444
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7151
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10806444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/806444 | Cosmetic composition comprising at least one fixing polymer and at least one amphoteric starch | Mar 22, 2004 | Abandoned |
Array
(
[id] => 7316842
[patent_doc_number] => 20040224018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Method of producing submicron particles of a labile agent and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/773124
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7506
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773124 | Method of producing submicron particles of a labile agent and use thereof | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7230416
[patent_doc_number] => 20040156859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Pulmonary delivery for bioconjugation'
[patent_app_type] => new
[patent_app_number] => 10/756774
[patent_app_country] => US
[patent_app_date] => 2004-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43232
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10756774
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/756774 | Pulmonary delivery for bioconjugation | Jan 11, 2004 | Abandoned |
Array
(
[id] => 7229977
[patent_doc_number] => 20040156819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Methods and compositions for reducing or eliminating post-surgical adhesion formation'
[patent_app_type] => new
[patent_app_number] => 10/749436
[patent_app_country] => US
[patent_app_date] => 2003-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18217
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10749436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/749436 | Methods and compositions for reducing or eliminating post-surgical adhesion formation | Dec 30, 2003 | Issued |
Array
(
[id] => 7199837
[patent_doc_number] => 20040086559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Pharmaceutical tablet comprising paroextine mesylate'
[patent_app_type] => new
[patent_app_number] => 10/250788
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4228
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086559.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250788
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250788 | Pharmaceutical tablet comprising paroextine mesylate | Dec 22, 2003 | Abandoned |
Array
(
[id] => 7322494
[patent_doc_number] => 20040137047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Pressure sensitive adhesive articles and methods for preparing same'
[patent_app_type] => new
[patent_app_number] => 10/744546
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13415
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10744546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/744546 | Pressure sensitive adhesive articles and methods for preparing same | Dec 21, 2003 | Abandoned |
Array
(
[id] => 7333392
[patent_doc_number] => 20040131646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Gel delivery vehicles for anticellular proliferative agents'
[patent_app_type] => new
[patent_app_number] => 10/741284
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12513
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741284
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741284 | Gel delivery vehicles for anticellular proliferative agents | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7333561
[patent_doc_number] => 20040131693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Composition with a base of a therapeutically active compound, in particular honey, for the treatment of wounds'
[patent_app_type] => new
[patent_app_number] => 10/398990
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1759
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398990 | Composition with a base of a therapeutically active compound, in particular honey, for the treatment of wounds | Dec 2, 2003 | Abandoned |
Array
(
[id] => 7468911
[patent_doc_number] => 20040096500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Controlled release oxycodone compositions'
[patent_app_type] => new
[patent_app_number] => 10/706371
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8657
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706371
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706371 | Controlled release oxycodone compositions | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7405881
[patent_doc_number] => 20040105887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Controlled release oxycodone compositions'
[patent_app_type] => new
[patent_app_number] => 10/706496
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8651
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20040105887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706496 | Controlled release oxycodone compositions | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7288511
[patent_doc_number] => 20040147581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy'
[patent_app_type] => new
[patent_app_number] => 10/702403
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41639
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147581.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702403 | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy | Nov 4, 2003 | Abandoned |
Array
(
[id] => 7368567
[patent_doc_number] => 20040092601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Antidepressant dosage form'
[patent_app_type] => new
[patent_app_number] => 10/696217
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7248
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696217 | Antidepressant dosage form | Oct 27, 2003 | Abandoned |
Array
(
[id] => 7199913
[patent_doc_number] => 20040086570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Antidepressant dosage form'
[patent_app_type] => new
[patent_app_number] => 10/696370
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7248
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086570.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696370
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696370 | Antidepressant dosage form | Oct 27, 2003 | Abandoned |
Array
(
[id] => 7164676
[patent_doc_number] => 20040076601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter'
[patent_app_type] => new
[patent_app_number] => 10/343822
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5114
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20040076601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343822 | Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter | Oct 23, 2003 | Abandoned |